OR WAIT null SECS
August 18, 2026
Video
Philippe Généreux, MD, discusses a secondary analysis of EARLY TAVR examining patients excluded from the trial for positive treadmill stress tests.
August 07, 2026
The phase 3 trial of evolocumab showed cardioprotective effects in patients without prior MI or stroke, regardless of qualifying atherosclerosis or background therapy.
August 01, 2026
Article
July saw some of the biggest FDA approvals so far in 2026 – catch up on what you might have missed!
July 31, 2026
All cardiovascular disease risks decreased proportionately across all quintiles of diet consistency, according to recent data.
July 30, 2026
Benjamin van Boxtel, MD, discusses the importance of familial screening for aortic dissection and the danger of missing potential risk factors.
CaRi-Heart measures coronary inflammation from routine CT angiography and generates a personalized 10-year cardiovascular mortality risk score.
July 16, 2026
A recent analysis of data from the Global Burden of Disease Study has indicated a relationship between risk of death from ACHD and socioeconomic factors.
July 15, 2026
These modifiable factors, among others, directly contribute to 88.7% of all IHD deaths in 2023.
July 14, 2026
Sripal Bangalore, MD, discusses his recent study proposing that early intervention can lead to better cardiovascular outcomes among these patients.
July 10, 2026
Richard Shi, MD, and Adam Tanious, MD, MBA, discuss the suboptimal number of patients at risk of long-term complications due to nonadherence.
